| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/27/2011 | WO2011011252A1 Methods of attenuating the loss of functional status |
| 01/27/2011 | WO2011011181A1 Pharmacological chaperones for the treatment of alzheimer's disease |
| 01/27/2011 | WO2011010769A1 Composition for treating or preventing diabetes comprising silk peptide as active ingredient |
| 01/27/2011 | WO2011010732A1 Composition for external preparation for skin |
| 01/27/2011 | WO2011010399A1 Corneal endothelial cell proliferation promoter |
| 01/27/2011 | WO2011010337A1 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 01/27/2011 | WO2011009961A1 Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis |
| 01/27/2011 | WO2011009757A2 Use of human beta-defensin to influence the natural pigmentation process |
| 01/27/2011 | WO2011009626A1 Compounds which inhibit muscle contraction |
| 01/27/2011 | WO2011009382A1 Use of polypeptide micromolecule mlif in preparing medicine for preventing and treating myocardial ischemia |
| 01/27/2011 | WO2011009218A1 Raf dimers and uses thereof |
| 01/27/2011 | WO2011009173A1 Cancer immunotherapy |
| 01/27/2011 | WO2010141312A3 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| 01/27/2011 | WO2010134814A3 Means and methods for counteracting polyq expansion disorders |
| 01/27/2011 | WO2010122506A3 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof |
| 01/27/2011 | WO2010121195A3 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein |
| 01/27/2011 | WO2010118384A3 Amylin agonist compounds for estrogen-deficient mammals |
| 01/27/2011 | WO2010117753A3 Peptide compositions for oral care systems |
| 01/27/2011 | WO2010112848A3 Inhibition of biofilm organisms |
| 01/27/2011 | WO2010090876A3 Satiation peptide administration |
| 01/27/2011 | WO2010088276A3 Polynucleotide aptamer-based cross -linked materials and uses thereof |
| 01/27/2011 | WO2010041150A3 Pharmaceutical peptides for the treatment of inflammatory diseases |
| 01/27/2011 | US20110023137 Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| 01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
| 01/27/2011 | US20110021974 Retinitis pigmentosa treatment and prophalaxis |
| 01/27/2011 | US20110021752 Tropoelastin Derivatives |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
| 01/27/2011 | US20110021445 Compositions and methods for treating erectile dysfunction |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021443 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/27/2011 | US20110021442 Cell preamble runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
| 01/27/2011 | US20110021440 Apoptotic pathway targeting for the diagnosis and treatment of cancer |
| 01/27/2011 | US20110021439 Use of transesterified olive oil in the cosmetic field |
| 01/27/2011 | US20110021438 Novel compounds of the n-acylamino-amide family, compositions comprising them and uses thereof |
| 01/27/2011 | US20110021437 Method for reducing pain with ziconotide and baclofen |
| 01/27/2011 | US20110021436 Method for reducing pain with ziconotide and morphine |
| 01/27/2011 | US20110021435 Composition for preventing or treating brain diseases |
| 01/27/2011 | US20110021434 Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof |
| 01/27/2011 | US20110021433 Methods for treating or preventing heart failure |
| 01/27/2011 | US20110021432 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | US20110021431 Methods And Compositions For Medical Articles Produced From Proteinaceous Compounds |
| 01/27/2011 | US20110021430 Modified vitamin k-dependent polypeptides |
| 01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
| 01/27/2011 | US20110021428 Prevention of allergy at weaning |
| 01/27/2011 | US20110021427 Biphasic calcium phosphate cement for drug delivery |
| 01/27/2011 | US20110021426 Methods for treatment of pain |
| 01/27/2011 | US20110021425 Tricyclic inhibitors of jak |
| 01/27/2011 | US20110021424 Polypeptide derived from protein a and able to bind pdgf |
| 01/27/2011 | US20110021423 Rapid Acting Insulin Analogues |
| 01/27/2011 | US20110021422 Method and compositions for prevention and treatment of diabetic and aged skin |
| 01/27/2011 | US20110021421 Liquid enteral nutritional composition with a low specific protein volume |
| 01/27/2011 | US20110021420 Modification of feeding behaviour |
| 01/27/2011 | US20110021419 Methods and Compositions for the Treatment of Heart Failure and Other Disorders |
| 01/27/2011 | US20110021418 Enriched haptoglobin polymers for the treatment of disease |
| 01/27/2011 | US20110021417 Compositions comprising oligosaccharides |
| 01/27/2011 | US20110021416 Compositions, methods and uses for treating bacterial infections |
| 01/27/2011 | US20110021415 Antimicrobial peptides |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
| 01/27/2011 | US20110021411 Reverse protein |
| 01/27/2011 | US20110021377 Use of a trpc channel for the treatment of a cardiovascular disease |
| 01/27/2011 | US20110020951 Purified sr-p70 protein |
| 01/27/2011 | US20110020895 Methods and compositions for determining isomerase enzymatic activity |
| 01/27/2011 | US20110020870 Methods for producing modified glycoproteins |
| 01/27/2011 | US20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 01/27/2011 | US20110020658 Metal implant coated under reduced oxygen concentration with osteoinductive protein |
| 01/27/2011 | US20110020471 Erythrocyte atp-release modulators |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110020458 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 01/27/2011 | US20110020457 Polymer-surfactant nanoparticles for sustained release of compounds |
| 01/27/2011 | US20110020449 Methods of treating disorders of the eye and surrounding tissue with thymosin beta 4 (tb4), analogues, isoforms and other derivatives |
| 01/27/2011 | US20110020438 Crystallization Inhibitor and Its Use in Gelatin Capsules |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |
| 01/27/2011 | US20110020435 Stabilizing alkylglycoside compositions and methods thereof |
| 01/27/2011 | US20110020434 Nanoparticle arsenic-platinum compositions |
| 01/27/2011 | US20110020433 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 01/27/2011 | US20110020432 Compositions and methods of use for post-radiation protection |
| 01/27/2011 | US20110020431 Antitumor effect of mutant bik |
| 01/27/2011 | US20110020428 Gel-stabilized liposome compositions, methods for their preparation and uses thereof |
| 01/27/2011 | US20110020421 Biodegradable polyphosphazenes containing pyrrolidone side groups |
| 01/27/2011 | US20110020418 Particulate Tissue Graft with Components of Differing Density and Methods of Making and Using the Same |
| 01/27/2011 | US20110020411 Factor replacement therapy |
| 01/27/2011 | US20110020409 Silk Fibroin Hydrogels and Uses Thereof |
| 01/27/2011 | US20110020405 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant |
| 01/27/2011 | US20110020398 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020372 Follistatin domain containing proteins |
| 01/27/2011 | US20110020367 Methods of Evaluating Transplant Rejection |
| 01/27/2011 | US20110020364 Methods and compositions involving pbef inhibitors for lung inflammation conditions and diseases |
| 01/27/2011 | US20110020362 Adrenergic stimulation mediates hypersensitivity by inducing nerve growth factor expression |
| 01/27/2011 | US20110020359 Methods and compositions for treating neuronal damage or degeneration |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020350 Contraceptives Based on SP22 and SP22 Antibodies |
| 01/27/2011 | US20110020348 Pharmaceutical compositions and methods using secreted frizzled related protein |